undamentalytics Newsletter
Sign in

Pulmonx Corp balance sheet

At the end of fiscal 2025, Pulmonx Corp had total assets of $129m, total liabilities of $75.2m and shareholders' equity of $54.1m. It held $69.8m in cash against $42.5m of debt: net cash of $27.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents41523214810284717056
Receivables—647912131212
Inventory—611161517171616
Total current assets—4125020816915013610288
Goodwill—22222222
Total assets—54264235194178163129115
Accounts payable—31221445
Deferred revenue (current)—00000000
Total current liabilities—1413181823242020
Short-term debt——0002300
Long-term debt——17171735343737
Total debt0018192246404262
Total liabilities—3638424059777576
Shareholders' equity−167−187226193154118865439
Non-controlling interests and other (assets − liabilities − equity)—205———————
Net debt (negative = net cash)−4−15−213−129−79−38−31−277
Shares outstanding—2m—37m38m39m40m42m43m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: IRMD vs LUNGLUNG vs SGHTDCTH vs LUNG

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Pulmonx Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pulmonx Corp.